Adams Respiratory Therapeutics, Inc. (ARXT) [Rocket]

In millions, except per share items	Jun-30-07	Jun-30-06	Jun-30-05	Jun-30-04	Jun-30-03	Jun-30-02
	10-K	10-K	10-K	10-K	10-K	S-1/A
Revenues	331.6	239.1	160.2	61.3	14.0	13.8
Revenue growth	38.7%	49.2%	161.4%	336.6%	2.1%
Cost of goods sold	95.8	49.4	31.1	11.9	5.3	4.0
Gross profit	235.8	189.7	129.1	49.4	8.8	9.7
Gross margin	71.1%	79.4%	80.6%	80.5%	62.6%	70.7%
Selling, general and administrative	162.9	99.0	78.0	23.3	23.3	18.0
Research and development	23.9	18.9	7.4	3.2	4.5	7.4
Other operating expenses	-1.2	-4.3	-0.8	3.2	7.2
EBITDA [+]	53.5	77.4	45.4	20.7	-25.0	-14.7
EBITDA growth	-30.9%	70.5%	118.9%	-182.9%	70.6%
EBITDA margin	16.1%	32.4%	28.3%	33.8%	-178.3%	-106.7%
Depreciation and amortization	3.2	1.3	1.0	1.0	1.2	1.0
EBIT [+]	50.3	76.2	44.4	19.7	-26.3	-15.7
EBIT growth	-34.0%	71.4%	125.5%	-175.0%	67.8%
EBIT margin	15.2%	31.8%	27.7%	32.1%	-187.1%	-113.8%
Interest expense, net [+]					3.6	-0.2
Interest expense					3.6
Interest income					0.0	0.2
Other income (expense), net	-2.7				7.2
Pre-tax income	47.6	76.2	44.4	19.7	-22.6	-15.5
Income taxes	17.0	29.8	17.4	-16.1	0.0	0.0
Tax rate	35.8%	39.1%	39.2%		0.0%	0.0%
Net income	0.0	0.0	-0.2	0.0	-22.6	-15.5
Net margin	0.0%	0.0%	-0.1%	0.0%	-161.3%	-112.5%

Basic EPS [+]	$0.86	$1.42	($32.97)	$1.64	($7,307.30)	($5.01)
Growth	-39.2%	-104.3%	-2105.2%	-100.0%	145800.4%
Diluted EPS [+]	$0.82	$1.28	($32.97)	$0.90	($7,307.30)	($5.01)
Growth	-35.5%	-103.9%	-3782.3%	-100.0%	145800.4%

Shares outstanding (basic) [+]	0.0	0.0	0.0	0.0	0.0	3.1
Growth	8.4%	423.0%	32.7%	51.7%	-99.9%
Shares outstanding (diluted) [+]	0.0	0.0	0.0	0.0	0.0	3.1
Growth	2.1%	482.9%	-27.7%	178.5%	-99.9%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.